cwp232291
Small moleculeexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2011 (NCT01398462)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Protein Wnt-3aINHIBITOR
WNT3A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cwp232291
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03055286 | Phase 1 | Mar 1, 2017 | JW Pharmaceutical |
| NCT02426723 | Phase 1 | Oct 1, 2015 | Catholic University of Korea, JW Pharmaceutical, Seoul National University, University of Texas at Houston, Yonsei University |
| NCT01398462 | Phase 1 | Jul 1, 2011 | JW Pharmaceutical |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| JW Pharmaceutical | For profit | 3 | 3 | 1 | 2011 |
| Catholic University of Korea | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Seoul National University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Texas at Houston | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Yonsei University | Academic/Hospital | 1 | 0 | 1 | 2015 |
5 organizations
Page 1 / 1